Guillon A, Aymeric S, Gaudy-Graffin C, Sonke J, Deblonde M P, Capsec J, Diot P, Garot D, Goudeau A, Grammatico-Guillon L
Service de Réanimation Polyvalente,CHRU de Tours,Université François Rabelais,CEPR, U1100, Tours,France.
Laboratoire de Santé Publique,CHRU de Tours,Université François Rabelais, EE Education Ethique Santé,Tours,France.
Epidemiol Infect. 2017 Oct;145(13):2766-2769. doi: 10.1017/S0950268817001029. Epub 2017 May 18.
The objective of this study was to determine how clinicians make use of the modern multiplex PCR assays (MPAs) to manage patients hospitalized for community-acquired pneumonia (CAP). We studied the use of MPAs in 1648 patients hospitalized for CAP over a 3-year period at the moment of the setup of the new PCR assay. We observed that the use of MPAs for the identification of multiple respiratory pathogens marks a radical change in the investigation of CAP etiology. Surprisingly, the contribution of MPAs to the medical decision-making process varies drastically according to the units of care.
本研究的目的是确定临床医生如何利用现代多重聚合酶链反应检测法(MPAs)来管理因社区获得性肺炎(CAP)住院的患者。在新的聚合酶链反应检测法建立之时,我们对1648例因CAP住院的患者进行了为期3年的MPAs使用情况研究。我们观察到,使用MPAs来鉴定多种呼吸道病原体标志着CAP病因调查的一个根本性变化。令人惊讶的是,MPAs对医疗决策过程的贡献因护理单元而异。